GlucoStabilizer®
FDA-cleared, software-guided intravenous insulin dosing for hospitals. JM2 Health implements and supports GlucoStabilizer as part of a coordinated inpatient glycemic management program.
Intravenous insulin is difficult to standardize on paper
IV insulin is among the highest-risk therapies on the ward. Managed with paper protocols, dosing depends on manual calculation under time pressure, varies between nurses and units, and is hard to audit after the fact. Software-guided dosing removes the arithmetic and applies the protocol the same way every time.
Software-guided dosing, built for the bedside
Automated dose calculation
Infusion rates are calculated by the software rather than worked out by hand at the bedside, removing a common source of error.
EMR integration
Results and documentation flow into existing electronic medical record systems instead of living in a separate silo.
Consistent protocol delivery
The same evidence-based protocol is applied the same way across nurses, shifts, units, and facilities.
Reduced nursing workload
No manual arithmetic, less documentation effort, and built-in prompts that help optimize testing frequency.
Safer glycemic control
Supports faster time to target range while reducing the risk of hypoglycemia during intravenous insulin therapy.
Reporting and oversight
Glucometric data supports quality improvement work and gives leadership visibility into performance.
The software is only half of it
Technology alone does not change practice. JM2 Health’s clinical experts lead implementation, train the care teams who use it, and stay involved afterwards — aligning the protocol with your existing workflows and keeping glycemic management consistent once the project team has moved on.
years running real diabetes programs
healthcare organizations served
patients managed on GlucoStabilizer®
Ready to make IV insulin management safer and more consistent?
Talk with a JM2 Health specialist about implementing GlucoStabilizer in your hospitals.